Biotech Investors & VC Firms in Global

911 firms in this list, with a median first check of $500K. 234 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
FI Fine Structures Ventures AJCDDNDM10 people	88🔒	Cambridge	US	Pre-Seed–Late Stage	—	+ Add to CRM
SA SABIC Ventures ASIFRWFH10 people	88🔒	Sittard	NL	Seed–Series A	$500K – $20M	+ Add to CRM
AX Axevil Capital AITCARAB9 people · Follows rounds	88🔒	San Francisco	US	Growth–Late Stage	—	+ Add to CRM
GR GRC Sinogreen EWA(BJ3 people	88🔒	Shenzhen	CN	Seed–Series A	—	+ Add to CRM
BO Boundary Capital DSDBMWAP5 people	88🔒	Northampton	GB	Pre-Seed–Series A	$190.5K – $635K	+ Add to CRM
DE DEFTA Partners GHKWM(MT11 people	88🔒	San Francisco	US	Seed–Series A	—	+ Add to CRM
BR Brunnur Ventures GP ÁBSAEÞÓF7 people	88🔒	Reykjavik	IS	Pre-Seed–Series A	$1M – $3M	+ Add to CRM
OU Outset Ventures MRSEABJG4 people · Leads rounds	88🔒	Auckland	NZ	Pre-Seed–Series B	$100K – $10M	+ Add to CRM
TE Tetragon Financial Group Limited BBDMPDRG15 people	88🔒	London	GB	Series C	—	+ Add to CRM
IN Infinitas Capital RLRHSLAC17 people	88🔒	—		Pre-Seed–Late Stage	—	+ Add to CRM
SE Serafund ACAZAWCC5 people	88🔒	Vancouver	CA	Pre-Seed–Late Stage	—	+ Add to CRM
VE Vectors Angel J(CZGWJH11 people	88🔒	—		Pre-Seed–Seed	—	+ Add to CRM
IN Innvotec Ltd. NDSPSTMT4 people	88🔒	London	GB	Series A–Series B	$317.5K – $635K	+ Add to CRM
TE Tensor Ventures MDRSOLDH10 people · Leads rounds	88🔒	Senningerberg	LU	Seed–Series A	—	+ Add to CRM
WI Wilbe Capital DTMAABAH13 people	88🔒	London	GB	Pre-Seed–Seed	$100K – $700K	+ Add to CRM
AR Arcanum Ventures CGSAASEC6 people · Follows rounds	88🔒	—	VN	Pre-Seed–Seed	$40K – $200K	+ Add to CRM
FI Finchley Healthcare Ventures DGMGPBTD15 people	88🔒	Montreal	US	Seed–Series A	—	+ Add to CRM
FU Future Positive Capital SFTWSHAT6 people · Follows rounds	88🔒	—	FR	Pre-Seed–Series A	—	+ Add to CRM
SO Solasta Ventures MJBCDYKG6 people	88🔒	Boston	US	Seed–Series B	—	+ Add to CRM
AT atai Life Sciences CASRAKAH16 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
EX Export and Investment Fund JBOHNJJL13 people	88🔒	København	DK	Pre-Seed–Growth	$108K – $7.6M	+ Add to CRM
PR Presight Capital CAFHMHMW4 people · Leads rounds	88🔒	Sliema	US	Pre-Seed–Late Stage	$500K – $20M	+ Add to CRM
AL Alta Semper Capital AJZKCO12 people · Leads rounds	88🔒	London	GB	Growth	$20M – $60M	+ Add to CRM
PE Perivoli Innovations JABM2 people	88🔒	St. Helier	GB	Pre-Seed–Series A	—	+ Add to CRM

Fine Structures Ventures

CambridgePre-Seed–Late Stage

AJCDDNDM10 people

SABIC Ventures

SittardSeed–Series A$500K – $20M

ASIFRWFH10 people

Axevil Capital

San FranciscoGrowth–Late Stage

AITCARAB9 people

GRC Sinogreen

ShenzhenSeed–Series A

EWA(BJ3 people

Boundary Capital

NorthamptonPre-Seed–Series A$190.5K – $635K

DSDBMWAP5 people

DEFTA Partners

San FranciscoSeed–Series A

GHKWM(MT11 people

Brunnur Ventures GP

ReykjavikPre-Seed–Series A$1M – $3M

ÁBSAEÞÓF7 people

Outset Ventures

AucklandPre-Seed–Series B$100K – $10M

MRSEABJG4 people

Tetragon Financial Group Limited

LondonSeries C

BBDMPDRG15 people

Infinitas Capital

Pre-Seed–Late Stage

RLRHSLAC17 people

Serafund

VancouverPre-Seed–Late Stage

ACAZAWCC5 people

Vectors Angel

Pre-Seed–Seed

J(CZGWJH11 people

Innvotec Ltd.

LondonSeries A–Series B$317.5K – $635K

NDSPSTMT4 people

Tensor Ventures

SenningerbergSeed–Series A

MDRSOLDH10 people

Wilbe Capital

LondonPre-Seed–Seed$100K – $700K

DTMAABAH13 people

Arcanum Ventures

Pre-Seed–Seed$40K – $200K

CGSAASEC6 people

Finchley Healthcare Ventures

MontrealSeed–Series A

DGMGPBTD15 people

Future Positive Capital

Pre-Seed–Series A

SFTWSHAT6 people

Solasta Ventures

BostonSeed–Series B

MJBCDYKG6 people

atai Life Sciences

New YorkSeed–Late Stage

CASRAKAH16 people

Export and Investment Fund

KøbenhavnPre-Seed–Growth$108K – $7.6M

JBOHNJJL13 people

Presight Capital

SliemaPre-Seed–Late Stage$500K – $20M

CAFHMHMW4 people

Alta Semper Capital

LondonGrowth$20M – $60M

AJZKCO12 people

Perivoli Innovations

St. HelierPre-Seed–Series A

JABM2 people

Data sourced from public filings and firms' own websites — see our methodology.